Vimarsana
Biggest News Aggregation in the World

Felix Study News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Felix Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Felix Study Today - Breaking & Trending Today

Obecabtagene Autoleucel (obe-cel, AUTO1) for Relapsed/Refractory Adult B-Cell Acute Lymphoblastic Leukemia (R/R B-ALL): Pooled Analysis of the Ongoing FELIX Phase Ib/II Study - Vimarsana News

Obecabtagene Autoleucel (obe-cel, AUTO1) for Relapsed/Refractory Adult B-Cell Acute Lymphoblastic Leukemia (R/R B-ALL): Pooled Analysis of the Ongoing FELIX Phase Ib/II Study

Claire Roddie, MD, PhD, presents data from the pooled analysis of the ongoing FELIX phase Ib/II study investigating obecabtagene autoleucel in patients with relapsed/refractory adult B-cell acute lymphoblastic leukemia.

Obe-Cel Elicits High Remission Rates in R/R B-ALL Irrespective of Leukemic Burden - Vimarsana News

Obe-Cel Elicits High Remission Rates in R/R B-ALL Irrespective of Leukemic Burden

Obecabtagene autoleucel elicited durable responses in patients with relapsed or refractory B-cell acute lymphoblastic leukemia independent of leukemic burden at lymphodepletion, although better outcomes were observed in those with lower burden.